{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:15:01Z","timestamp":1790644501625,"version":"4.1.0"},"reference-count":177,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2019,8,27]]},"DOI":"10.3233\/jhd-190366","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T10:41:58Z","timestamp":1563532918000},"page":"245-256","source":"Crossref","is-referenced-by-count":27,"title":["Glycation in Huntington\u2019s Disease: A Possible Modifier and Target for Intervention"],"prefix":"10.1177","volume":"8","author":[{"given":"In\u00eas Caldeira","family":"Br\u00e1s","sequence":"first","affiliation":[{"name":"Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekatrin","family":"K\u00f6nig","sequence":"additional","affiliation":[{"name":"Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Fleming","family":"Outeiro","sequence":"additional","affiliation":[{"name":"Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany"},{"name":"Max Planck Institute for Experimental Medicine, G\u00f6ttingen, Germany"},{"name":"Institute of Neuroscience, The Medical School, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-190366_ref1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality","volume":"28","author":"Chaudhuri","year":"2018","journal-title":"Cell Metab"},{"key":"10.3233\/JHD-190366_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.3233\/JHD-190366_ref3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","article-title":"Neurodegenerative disorders associated with diabetes mellitus","volume":"82","author":"Ristow","year":"2004","journal-title":"J Mol Med"},{"key":"10.3233\/JHD-190366_ref4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"Farrer","year":"1985","journal-title":"Clin Genet"},{"key":"10.3233\/JHD-190366_ref5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(72)91092-6","article-title":"Increased frequency of diabetes mellitus in patients with Huntington\u2019s chorea","volume":"1","author":"Podolsky","year":"1972","journal-title":"Lancet"},{"key":"10.3233\/JHD-190366_ref6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JHD-170253","article-title":"Huntington\u2019s disease and diabetes: Chronological sequence of its association","volume":"6","author":"Montojo","year":"2017","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-190366_ref7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington\u2019s disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-190366_ref8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.38.8.1292","article-title":"Glucose metabolism alterations in Friedreich\u2019s ataxia","volume":"38","author":"Finocchiaro","year":"1988","journal-title":"Neurology"},{"key":"10.3233\/JHD-190366_ref9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/BF00401372","article-title":"Hyperproinsulinaemia in patients with myotonic dystrophy","volume":"35","author":"Krentz","year":"1992","journal-title":"Diabetologia"},{"key":"10.3233\/JHD-190366_ref10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.3233\/JHD-190366_ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington\u2019s disease gene: Evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somat Cell Mol Genet"},{"key":"10.3233\/JHD-190366_ref12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/ajcn\/50.1.145","article-title":"Nutritional evaluation of Huntington disease patients","volume":"50","author":"Morales","year":"1989","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JHD-190366_ref13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.nut.2004.12.012","article-title":"Use of oral nutritional supplements in patients with Huntington\u2019s disease","volume":"21","author":"Trejo","year":"2005","journal-title":"Nutrition"},{"key":"10.3233\/JHD-190366_ref14","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190366_ref15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington\u2019s disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JHD-190366_ref16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.2007.18.3-4.223","article-title":"Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington\u2019s disease: Clinical consequences and therapeutic implications","volume":"18","author":"Aziz","year":"2007","journal-title":"Rev Neurosci"},{"key":"10.3233\/JHD-190366_ref17","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00415-009-0062-8","article-title":"Weight loss in neurodegenerative disorders","volume":"255","author":"Aziz","year":"2008","journal-title":"J Neurol"},{"key":"10.3233\/JHD-190366_ref18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington\u2019s disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"10.3233\/JHD-190366_ref19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington\u2019s disease develops diabetes due to deficient \u03b2-cell mass and exocytosis","volume":"14","author":"Bj\u00f6rkqvist","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/db08-0799","article-title":"Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington\u2019s disease","volume":"58","author":"Martin","year":"2009","journal-title":"Diabetes"},{"key":"10.3233\/JHD-190366_ref21","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1093\/hmg\/ddp336","article-title":"Mutant huntingtin interacts with beta-tubulin and disrupts vesicular transport and insulin secretion","volume":"18","author":"Smith","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington\u2019s disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-190366_ref23","doi-asserted-by":"crossref","unstructured":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72:971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.3233\/JHD-190366_ref24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet"},{"key":"10.3233\/JHD-190366_ref25","doi-asserted-by":"crossref","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: Mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JHD-190366_ref26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","article-title":"Widespread expression of Huntington\u2019s disease gene (IT15) protein product","volume":"14","author":"Sharp","year":"1995","journal-title":"Neuron"},{"key":"10.3233\/JHD-190366_ref27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1006\/bbrc.1997.7337","article-title":"Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells","volume":"238","author":"Onodera","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JHD-190366_ref28","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1098\/rstb.1999.0455","article-title":"Evidence for a recruitment and sequestration mechanism in Huntington\u2019s disease","volume":"354","author":"Preisinger","year":"1999","journal-title":"Philos Trans R Soc L B Biol Sci"},{"key":"10.3233\/JHD-190366_ref29","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.3233\/JHD-190366_ref30","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190366_ref31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1749-6632.1999.tb07826.x","article-title":"Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament network","volume":"893","author":"Nagai","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JHD-190366_ref32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","article-title":"Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain","volume":"20","author":"Senut","year":"2000","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-190366_ref33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-190366_ref34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00005072-199007000-00002","article-title":"Atrophy of the hypothalamic lateral tuberal nucleus in Huntington\u2019s disease","volume":"49","author":"Kremer","year":"1990","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-190366_ref35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(91)90443-W","article-title":"The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington\u2019s disease","volume":"132","author":"Kremer","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-190366_ref36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.62.3.523-a","article-title":"Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis","volume":"62","author":"Kassubek","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JHD-190366_ref37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.3233\/JHD-190366_ref39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-190366_ref40","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","article-title":"Huntingtin: An iron-regulated protein essential for normal nuclear and perinuclear organelles","volume":"9","author":"Hilditch-Maguire","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref41","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington\u2019s disease: A synaptopathy","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.3233\/JHD-190366_ref43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: Interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.3233\/JHD-190366_ref44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","article-title":"Loss of normal huntingtin function: New developments in Huntington\u2019s disease research","volume":"24","author":"Cattaneo","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.3233\/JHD-190366_ref45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: An alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JHD-190366_ref46","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1176\/appi.ajp.2007.07071201","article-title":"Huntington\u2019s disease: Getting closer","volume":"164","author":"Greenamyre","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JHD-190366_ref47","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","article-title":"Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner","volume":"28","author":"Benn","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-190366_ref48","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington\u2019s disease","volume":"29","author":"Gusella","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-190366_ref49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuropsychologia.2018.10.017","article-title":"An active cognitive lifestyle as a potential neuroprotective factor in Huntington\u2019s disease","volume":"122","author":"Garcia-Gorro","year":"2019","journal-title":"Neuropsychologia"},{"key":"10.3233\/JHD-190366_ref50","doi-asserted-by":"crossref","first-page":"e0161106","DOI":"10.1371\/journal.pone.0161106","article-title":"COMT Val158Met polymorphism modulates Huntington\u2019s disease progression","volume":"11","author":"de Diego-Balaguer","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190366_ref51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/JGP.0b013e318196a632","article-title":"Modeling brain reserve: Experience-dependent neuronal plasticity in healthy and Huntington\u2019s disease transgenic mice","volume":"17","author":"Nithianantharajah","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JHD-190366_ref52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington\u2019s disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JHD-190366_ref53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: Shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-190366_ref54","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: Widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-190366_ref55","doi-asserted-by":"crossref","first-page":"28676","DOI":"10.1074\/jbc.M114.563593","article-title":"Extending the spectrum of \u03b1-dicarbonyl compounds in vivo","volume":"289","author":"Henning","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn2294","article-title":"Glucose neurotoxicity","volume":"9","author":"Tomlinson","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JHD-190366_ref57","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2174\/1389200217666151222155216","article-title":"Methylglyoxal, A metabolite increased in diabetes is associated with insulin resistance, vascular dysfunction and neuropathies","volume":"17","author":"Shamsaldeen","year":"2016","journal-title":"Curr Drug Metab"},{"key":"10.3233\/JHD-190366_ref58","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","article-title":"Evidence of oxidative stress in the neocortex in incidental Lewy body disease","volume":"64","author":"Dalf\u00f3","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-190366_ref59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/iub.1450","article-title":"Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches","volume":"67","author":"Ashraf","year":"2015","journal-title":"IUBMB Life"},{"key":"10.3233\/JHD-190366_ref60","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J"},{"key":"10.3233\/JHD-190366_ref61","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2337\/diabetes.52.11.2767","article-title":"Extracellular glucose in rat ventromedial hypothalamus during acute and recurrent hypoglycemia","volume":"52","author":"de Vries","year":"2003","journal-title":"Diabetes"},{"key":"10.3233\/JHD-190366_ref62","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1523\/JNEUROSCI.14-08-05068.1994","article-title":"Extracellular glucose concentration in mammalian brain: Continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals","volume":"14","author":"Silver","year":"1994","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-190366_ref63","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00004647-200203000-00004","article-title":"Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: Effects of hyperglycemia and hypoglycemia","volume":"22","author":"Abi-Saab","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JHD-190366_ref64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn2294","article-title":"Glucose neurotoxicity","volume":"9","author":"Tomlinson","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JHD-190366_ref65","doi-asserted-by":"crossref","first-page":"95913","DOI":"10.1172\/jci.insight.95913","article-title":"Blunted rise in brain glucose levels during hyperglycemia in adults with obesity and T2DM","volume":"2","author":"Hwang","year":"2017","journal-title":"JCI insight"},{"key":"10.3233\/JHD-190366_ref66","first-page":"1986","article-title":"Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans","volume":"86","author":"Hasselbalch","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JHD-190366_ref67","first-page":"66","article-title":"Action des acides amines sur les sucre: Formation des melanoidines par voie methodique","author":"Maillard","year":"1912","journal-title":"C R Hebd Seances Acad Sci"},{"key":"10.3233\/JHD-190366_ref68","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10719-016-9694-y","article-title":"Pathways of the Maillard reaction under physiological conditions","volume":"33","author":"Henning","year":"2016","journal-title":"Glycoconj J"},{"key":"10.3233\/JHD-190366_ref69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344 Pt 1","author":"Thornalley","year":"1999","journal-title":"Biochem J"},{"key":"10.3233\/JHD-190366_ref70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: A review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.3233\/JHD-190366_ref71","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1038\/s41598-017-03691-z","article-title":"Evolution of complex Maillard chemical reactions, resolved in time","volume":"7","author":"Hemmler","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-190366_ref72","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/ijms18050984","article-title":"Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention","volume":"18","author":"Brings","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"10.3233\/JHD-190366_ref73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic Res"},{"key":"10.3233\/JHD-190366_ref74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2690001","article-title":"The glyoxalase system: New developments towards functional characterization of a metabolic pathway fundamental to biological life","volume":"269","author":"Thornalley","year":"1990","journal-title":"Biochem J"},{"key":"10.3233\/JHD-190366_ref75","first-page":"e343","article-title":"Association of two glyoxalase I gene polymorphisms with nephropathy and retinopathy in Type 2 diabetes","volume":"34","author":"Wu","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.3233\/JHD-190366_ref76","first-page":"4364","article-title":"Reduction of trioses by NADPH-dependent aldo-keto reductases","volume":"267","author":"Vander Jagt","year":"1992","journal-title":"Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem"},{"key":"10.3233\/JHD-190366_ref77","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2337\/diab.41.10.1286","article-title":"Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM","volume":"41","author":"Sell","year":"1992","journal-title":"Diabetes"},{"key":"10.3233\/JHD-190366_ref78","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00726-010-0778-x","article-title":"The pathogenic role of Maillard reaction in the aging eye","volume":"42","author":"Nagaraj","year":"2012","journal-title":"Amino Acids"},{"key":"10.3233\/JHD-190366_ref79","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1073\/pnas.81.2.583","article-title":"Accelerated age-related browning of human collagen in diabetes mellitus","volume":"81","author":"Monnier","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190366_ref80","first-page":"1","article-title":"Toward a Maillard reaction theory of aging","volume":"304","author":"Monnier","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.3233\/JHD-190366_ref81","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1532-5415.2009.02438.x","article-title":"Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults","volume":"57","author":"Semba","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JHD-190366_ref82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1474-9726.2008.00371.x","article-title":"Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans","volume":"7","author":"Morcos","year":"2008","journal-title":"Aging Cell"},{"key":"10.3233\/JHD-190366_ref83","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.cub.2016.09.024","article-title":"A Caenorhabditis elegans model elucidates a conserved role for TRPA1-Nrf signaling in reactive \u03b1-dicarbonyl detoxification","volume":"26","author":"Chaudhuri","year":"2016","journal-title":"Curr Biol"},{"key":"10.3233\/JHD-190366_ref84","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/brain\/awx056","article-title":"Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies","volume":"140","author":"VicenteMiranda","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JHD-190366_ref85","doi-asserted-by":"crossref","first-page":"14987","DOI":"10.1016\/S0021-9258(18)42137-0","article-title":"Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface","volume":"267","author":"Schmidt","year":"1992","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref86","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.3390\/ijms141019891","article-title":"Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond","volume":"14","author":"Daffu","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JHD-190366_ref87","doi-asserted-by":"crossref","first-page":"31740","DOI":"10.1074\/jbc.274.44.31740","article-title":"N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression","volume":"274","author":"Kislinger","year":"1999","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref88","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/35012626","article-title":"Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases","volume":"405","author":"Taguchi","year":"2000","journal-title":"Nature"},{"key":"10.3233\/JHD-190366_ref89","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.3233\/JHD-190366_ref90","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis","volume":"6","author":"Yan","year":"2000","journal-title":"Nat Med"},{"key":"10.3233\/JHD-190366_ref91","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis","volume":"106","author":"Yan","year":"2010","journal-title":"Circ Res"},{"key":"10.3233\/JHD-190366_ref92","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","article-title":"Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications","volume":"1243","author":"Ramasamy","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JHD-190366_ref93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JPD-171285","article-title":"Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson\u2019s disease","volume":"8","author":"K\u00f6nig","year":"2018","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JHD-190366_ref94","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/mds.26566","article-title":"Glycation in Parkinson\u2019s disease and Alzheimer\u2019s disease","volume":"31","author":"Vicente Miranda","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-190366_ref95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(96)00729-9","article-title":"Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease","volume":"737","author":"Castellani","year":"1996","journal-title":"Brain Res"},{"key":"10.3233\/JHD-190366_ref96","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2015.02.069","article-title":"A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson\u2019s disease","volume":"459","author":"Xie","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JHD-190366_ref97","doi-asserted-by":"crossref","first-page":"40699","DOI":"10.1038\/srep40699","article-title":"DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function","volume":"7","author":"Plotegher","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-190366_ref98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbapap.2008.11.016","article-title":"The modification of \u03b1-synuclein by dicarbonyl compounds inhibits its fibril-forming process","volume":"1794","author":"Lee","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 2","key":"10.3233\/JHD-190366_ref99","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-2011-101965","article-title":"Role of advanced glycation on aggregation and DNA binding properties of \u03b1-synuclein","volume":"24","author":"Padmaraju","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JHD-190366_ref100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0925-4439(96)00062-2","article-title":"Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide","volume":"1360","author":"Munch","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JHD-190366_ref101","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to amyloidosis in Alzheimer disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190366_ref102","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1016\/S0021-9258(17)31849-5","article-title":"Analysis of microtubule-associated protein tau glycation in paired helical filaments","volume":"269","author":"Ledesma","year":"1994","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref103","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JAD-2003-5607","article-title":"Advanced glycation endproduct precursor alters intracellular amyloid-beta\/A beta PP carboxy-terminal fragment aggregation and cytotoxicity","volume":"5","author":"Woltjer","year":"2003","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JHD-190366_ref104","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.freeradbiomed.2010.05.005","article-title":"Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species","volume":"49","author":"Ko","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JHD-190366_ref105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.1985.tb00185.x","article-title":"Diabetes mellitus in Huntington disease","volume":"27","author":"Farrer","year":"1985","journal-title":"Clin Genet"},{"key":"10.3233\/JHD-190366_ref106","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-131847","article-title":"High prevalence of diabetes mellitus in a five-generation Chinese family with Huntington\u2019s disease","volume":"40","author":"Hu","year":"2014","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.3233\/JHD-190366_ref107","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease","volume":"65","author":"Lali\u0107","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-190366_ref108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-120044","article-title":"Proteomic analysis of the human brain in Huntington\u2019s Disease indicates pathogenesis by molecular processes linked to other neurodegenerative diseases and to type-2 diabetes","volume":"2","author":"Sch\u00f6nberger","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-190366_ref109","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0022-510X(89)90120-2","article-title":"Endocrine functions in Huntington\u2019s disease. A two-and-a-half years follow-up study","volume":"90","author":"Kremer","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.3233\/JHD-190366_ref110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/jnnp.44.5.414","article-title":"Studies of hypothalamic function in Huntington\u2019s chorea","volume":"44","author":"Lavin","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-190366_ref111","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.39.3.244","article-title":"Altered growth hormone release in Huntington\u2019s chorea","volume":"39","author":"Keogh","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-190366_ref112","doi-asserted-by":"crossref","first-page":"e0146480","DOI":"10.1371\/journal.pone.0146480","article-title":"A metabolic study of Huntington\u2019s disease","volume":"11","author":"Nambron","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190366_ref113","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JHD-130078","article-title":"Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington\u2019s disease patients","volume":"2","author":"Russo","year":"2013","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-190366_ref114","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jamda.2014.01.010","article-title":"Clinical, demographic, and pharmacologic features of nursing home residents with Huntington\u2019s disease","volume":"15","author":"Zarowitz","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"10.3233\/JHD-190366_ref115","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","article-title":"Huntington\u2019s disease does not appear to increase the risk of diabetes mellitus","volume":"21","author":"Boesgaard","year":"2009","journal-title":"J Neuroendocrinol"},{"key":"10.3233\/JHD-190366_ref116","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington\u2019s disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"key":"10.3233\/JHD-190366_ref117","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2826.2007.01629.x","article-title":"Impaired glucose tolerance in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"20","author":"Josefsen","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.3233\/JHD-190366_ref118","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190366_ref119","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","article-title":"Formation of polyglutamine inclusions in non-CNS tissue","volume":"8","author":"Sathasivam","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00418-008-0393-z","article-title":"Islet beta-cell area and hormone expression are unaltered in Huntington\u2019s disease","volume":"129","author":"Bacos","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.3233\/JHD-190366_ref121","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.brainresbull.2011.01.009","article-title":"Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6\/2 mouse model of Huntington\u2019s disease","volume":"87","author":"Anzilotti","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.3233\/JHD-190366_ref122","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2004.05.052","article-title":"Expression of the receptor for advanced glycation end products in Huntington\u2019s disease caudate nucleus","volume":"1018","author":"Ma","year":"2004","journal-title":"Brain Res"},{"key":"10.3233\/JHD-190366_ref123","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/jnc.13178","article-title":"The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington\u2019s disease","volume":"134","author":"Kim","year":"2015","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-190366_ref124","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/jbc.M114.597815","article-title":"Parkinsonism-associated protein DJ-1\/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues","volume":"290","author":"Richarme","year":"2015","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref125","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/hmg\/dds155","article-title":"Human DJ-1 and its homologs are novel glyoxalases","volume":"21","author":"Lee","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref126","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/hmg\/ddt466","article-title":"DJ-1 modulates aggregation and pathogenesis in models of Huntington\u2019s disease","volume":"23","author":"Sajjad","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref127","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","article-title":"Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation","volume":"20","author":"Ribchester","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JHD-190366_ref128","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/sj.cdd.4401967","article-title":"Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington\u2019s disease subjects","volume":"13","author":"Ciammola","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.3233\/JHD-190366_ref129","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington\u2019s disease","volume":"4","author":"Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"10.3233\/JHD-190366_ref130","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","article-title":"Gene expression in Huntington\u2019s disease skeletal muscle: A potential biomarker","volume":"14","author":"Strand","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref131","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: Parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-190366_ref132","doi-asserted-by":"crossref","first-page":"36798","DOI":"10.1038\/srep36798","article-title":"Glycation potentiates neurodegeneration in models of Huntington\u2019s disease","volume":"6","author":"Vicente Miranda","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JHD-190366_ref133","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13311-013-0244-z","article-title":"Treatment of Huntington\u2019s disease","volume":"11","author":"Frank","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JHD-190366_ref134","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/fnl-2017-0035","article-title":"New directions in therapeutics for Huntington disease","volume":"13","author":"Potkin","year":"2018","journal-title":"Futur Neurol"},{"key":"10.3233\/JHD-190366_ref135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrd.2018.133","article-title":"Therapeutic approaches to Huntington disease: From the bench to the clinic","volume":"17","author":"Caron","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JHD-190366_ref136","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archneur.65.4.476","article-title":"Glucose homeostasis in Huntington disease: Abnormalities in insulin sensitivity and early-phase insulin secretion","volume":"65","author":"Lalic","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JHD-190366_ref137","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fphys.2014.00231","article-title":"Metabolic and hormonal signatures in pre-manifest and manifest Huntington\u2019s disease patients","volume":"5","author":"Wang","year":"2014","journal-title":"Front Physiol"},{"key":"10.3233\/JHD-190366_ref138","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JHD-170253","article-title":"Huntington\u2019s disease and diabetes: Chronological sequence of its association","volume":"6","author":"Montojo","year":"2017","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-190366_ref139","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.110.166470","article-title":"Transferrin fusion technology: A novel approach to prolonging biological half-life of insulinotropic peptides","volume":"334","author":"Kim","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JHD-190366_ref140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","article-title":"Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease","volume":"225","author":"Ho","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-190366_ref141","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.3233\/JHD-190366_ref142","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington\u2019s disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp Brain Res"},{"key":"10.3233\/JHD-190366_ref143","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1210\/jcem.87.3.8337","article-title":"The insulinotropic effect of acute exendin-4 administered to humans: Comparison of nondiabetic state to type 2 diabetes","volume":"87","author":"Egan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JHD-190366_ref144","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000338464","article-title":"Glucagon-like peptide-1 agonist exendin-4 leads to reduction of weight and caloric intake in a rat model of hypothalamic obesity","volume":"78","author":"Elfers","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"10.3233\/JHD-190366_ref145","doi-asserted-by":"crossref","first-page":"31766","DOI":"10.1074\/jbc.M112.387316","article-title":"Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy","volume":"287","author":"Martin","year":"2012","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-190366_ref146","doi-asserted-by":"crossref","first-page":"38744","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease","volume":"7","author":"Arnoux","year":"2018","journal-title":"Elife. e"},{"key":"10.3233\/JHD-190366_ref147","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2006.10.039","article-title":"Metformin therapy in a transgenic mouse model of Huntington\u2019s disease","volume":"411","author":"Ma","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-190366_ref148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","article-title":"Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective","volume":"317","author":"Li","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.3233\/JHD-190366_ref149","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0002-9440(10)63917-X","article-title":"Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis","volume":"162","author":"Rocken","year":"2003","journal-title":"Am J Pathol"},{"key":"10.3233\/JHD-190366_ref150","doi-asserted-by":"crossref","first-page":"16R","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"key":"10.3233\/JHD-190366_ref151","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neubiorev.2015.12.006","article-title":"RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis","volume":"62","author":"Ray","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JHD-190366_ref152","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1073\/pnas.93.9.3902","article-title":"Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine","volume":"93","author":"Li","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-190366_ref153","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0272-6386(95)90051-9","article-title":"Advanced glycosylation end products in diabetic renal and vascular disease","volume":"26","author":"Bucala","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.3233\/JHD-190366_ref154","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0197-2456(99)00024-0","article-title":"Design and baseline characteristics for the aminoguanidine clinical trial in overt type 2 diabetic nephropathy (ACTION II)","volume":"20","author":"Freedman","year":"1999","journal-title":"Control Clin Trials"},{"key":"10.3233\/JHD-190366_ref155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"Thornalley","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.3233\/JHD-190366_ref156","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000075627","article-title":"Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy","volume":"24","author":"Bolton","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.3233\/JHD-190366_ref157","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2005.10.022","article-title":"Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha","volume":"394","author":"Wu","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-190366_ref158","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157339905774574383","article-title":"The potential role of thiamine (vitamin B1) in diabetic complications","volume":"1","author":"Thornalley","year":"2005","journal-title":"Curr Diabetes Rev"},{"key":"10.3233\/JHD-190366_ref159","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1010052800347","article-title":"AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs","volume":"2","author":"Dukic-Stefanovic","year":"2001","journal-title":"Biogerontology"},{"key":"10.3233\/JHD-190366_ref160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.exger.2010.03.001","article-title":"Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer\u2019s disease","volume":"45","author":"Krautwald","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.3233\/JHD-190366_ref161","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00125-008-1224-4","article-title":"High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: A randomised, double-blind placebo-controlled pilot study","volume":"52","author":"Rabbani","year":"2009","journal-title":"Diabetologia"},{"key":"10.3233\/JHD-190366_ref162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02260940","article-title":"The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation","volume":"8","author":"Munch","year":"1994","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.3233\/JHD-190366_ref163","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF03033780","article-title":"The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal","volume":"7","author":"Webster","year":"2005","journal-title":"Neurotox Res"},{"key":"10.3233\/JHD-190366_ref164","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fnins.2018.00381","article-title":"Linking glycation and glycosylation with inflammation and mitochondrial dysfunction in Parkinson\u2019s disease","volume":"12","author":"Videira","year":"2018","journal-title":"Front Neurosci"},{"key":"10.3233\/JHD-190366_ref165","doi-asserted-by":"crossref","first-page":"105828","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and oxidative stress: The molecular connectivity between insulin resistance, obesity, and Alzheimer\u2019s disease","volume":"2015","author":"Verdile","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.3233\/JHD-190366_ref166","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-019-03550-7"},{"key":"10.3233\/JHD-190366_ref167","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/cells8050385","article-title":"Pinocembrin protects from AGE-induced cytotoxicity and inhibits non-enzymatic glycation in human insulin","volume":"8","author":"Borriello","year":"2019","journal-title":"Cells"},{"key":"10.3233\/JHD-190366_ref168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/8748253","article-title":"Beneficial role of phytochemicals on oxidative stress and age-related diseases","volume":"2019","author":"Forni","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.3233\/JHD-190366_ref169","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.drudis.2006.05.016","article-title":"Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases","volume":"11","author":"Reddy","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.3233\/JHD-190366_ref170","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.phymed.2003.12.002","article-title":"Aldose reductase inhibitors from the leaves of Myrciaria dubia (H.B. & K.) McVaugh","volume":"11","author":"Ueda","year":"2004","journal-title":"Phytomedicine"},{"key":"10.3233\/JHD-190366_ref171","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/np0503698","article-title":"Phenolic marine natural products as aldose reductase inhibitors","volume":"69","author":"Manzanaro","year":"2006","journal-title":"J Nat Prod"},{"key":"10.3233\/JHD-190366_ref172","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF02969270","article-title":"Naphthopyrone glucosides from the seeds of Cassia tora with inhibitory activity on advanced glycation end products (AGEs) formation","volume":"29","author":"Lee","year":"2006","journal-title":"Arch Pharm Res"},{"key":"10.3233\/JHD-190366_ref173","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-319-28383-8_8","article-title":"Impact of non-enzymatic glycation in neurodegenerative diseases: Role of natural products in prevention","volume":"12","author":"Ahmad","year":"2016","journal-title":"Adv Neurobiol"},{"key":"10.3233\/JHD-190366_ref174","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","article-title":"Targeting the receptor for advanced glycation endproducts (RAGE): A medicinal chemistry perspective","volume":"60","author":"Bongarzone","year":"2017","journal-title":"J Med Chem"},{"key":"10.3233\/JHD-190366_ref175","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JHD-190366_ref176","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acschemneuro.5b00319","article-title":"Synthesis and evaluation of [(18)F]RAGER: A first generation small-molecule PET radioligand targeting the receptor for advanced glycation endproducts","volume":"7","author":"Cary","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JHD-190366_ref177","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/jgs.12816","article-title":"Alzheimer\u2019s Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: A longitudinal study","volume":"62","author":"Zhu","year":"2014","journal-title":"J Am Geriatr Soc"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-190366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:50:51Z","timestamp":1777452651000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-190366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":177,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jhd-190366","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]}}}